Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn’s Disease

Table 2

Comparison of growth recovery in EEN and IFX groups.

	EEN ()	IFX ()
HFA z-score
Baseline	−0.7 ± 1.6	−0.1 ± 1.2
After 8 weeks	−0.5 ± 1.6^#	−0.2 ± 1.1
Change in HFA z-score	0.1 ± 0.4	−0.1 ± 0.3
BMIFA z-score
Baseline	−1.5 ± 1.3	−1.9 ± 1.1
After 8 weeks	−0.4 ± 1.3	−0.7 ± 0.9
Change in BMIFA z-score	1.2 ± 0.7	1.2 ± 0.8

EEN: exclusive enteral nutrition; IFX: infliximab; PCDAI: pediatric Crohn’s disease activity index; HFA: height for age; BMFAI: body mass index for age. ^#; .